Japan · Delayed Price · Currency is JPY MT Genex Statistics
Total Valuation
MT Genex has a market cap or net worth of JPY 3.84 billion. The enterprise value is 1.93 billion.
| Market Cap | 3.84B |
| Enterprise Value | 1.93B |
Important Dates
The last earnings date was Monday, May 11, 2026.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
MT Genex has 1.08 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 1.08M |
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 5.48% |
| Owned by Institutions (%) | 2.42% |
| Float | 270,466 |
Valuation Ratios
The trailing PE ratio is 12.24.
| PE Ratio | 12.24 |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | 69.86 |
| P/OCF Ratio | 48.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.62, with an EV/FCF ratio of 35.13.
| EV / Earnings | 6.15 |
| EV / Sales | 0.41 |
| EV / EBITDA | 3.62 |
| EV / EBIT | 4.16 |
| EV / FCF | 35.13 |
Financial Position
The company has a current ratio of 5.88, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.88 |
| Quick Ratio | 3.48 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 1.51 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.36% and return on invested capital (ROIC) is 12.62%.
| Return on Equity (ROE) | 7.36% |
| Return on Assets (ROA) | 5.39% |
| Return on Invested Capital (ROIC) | 12.62% |
| Return on Capital Employed (ROCE) | 9.72% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | 35.18M |
| Profits Per Employee | 2.34M |
| Employee Count | 134 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 249.45 |
Taxes
In the past 12 months, MT Genex has paid 176.00 million in taxes.
| Income Tax | 176.00M |
| Effective Tax Rate | 35.92% |
Stock Price Statistics
The stock price has increased by +27.59% in the last 52 weeks. The beta is 0.22, so MT Genex's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +27.59% |
| 50-Day Moving Average | 3,668.10 |
| 200-Day Moving Average | 3,449.72 |
| Relative Strength Index (RSI) | 48.67 |
| Average Volume (20 Days) | 1,285 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MT Genex had revenue of JPY 4.71 billion and earned 314.00 million in profits. Earnings per share was 291.74.
| Revenue | 4.71B |
| Gross Profit | 1.10B |
| Operating Income | 464.00M |
| Pretax Income | 490.00M |
| Net Income | 314.00M |
| EBITDA | 534.00M |
| EBIT | 464.00M |
| Earnings Per Share (EPS) | 291.74 |
Balance Sheet
The company has 1.99 billion in cash and 83.00 million in debt, with a net cash position of 1.91 billion or 1,774.65 per share.
| Cash & Cash Equivalents | 1.99B |
| Total Debt | 83.00M |
| Net Cash | 1.91B |
| Net Cash Per Share | 1,774.65 |
| Equity (Book Value) | 4.40B |
| Book Value Per Share | 4,088.20 |
| Working Capital | 4.25B |
Cash Flow
In the last 12 months, operating cash flow was 79.00 million and capital expenditures -24.00 million, giving a free cash flow of 55.00 million.
| Operating Cash Flow | 79.00M |
| Capital Expenditures | -24.00M |
| Depreciation & Amortization | 70.00M |
| Net Borrowing | -17.00M |
| Free Cash Flow | 55.00M |
| FCF Per Share | 51.10 |
Margins
Gross margin is 23.27%, with operating and profit margins of 9.84% and 6.66%.
| Gross Margin | 23.27% |
| Operating Margin | 9.84% |
| Pretax Margin | 10.39% |
| Profit Margin | 6.66% |
| EBITDA Margin | 11.33% |
| EBIT Margin | 9.84% |
| FCF Margin | 1.17% |
Dividends & Yields
This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 1.13%.
| Dividend Per Share | 40.00 |
| Dividend Yield | 1.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.38% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 1.09% |
| Earnings Yield | 8.17% |
| FCF Yield | 1.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2017. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
MT Genex has an Altman Z-Score of 4.54 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.54 |
| Piotroski F-Score | 5 |